ÂÜÀòÂÒÂ×

Daekyeong Bae is a seasoned professional with extensive experience in the biopharmaceutical and healthcare sectors. Currently serving as Senior Director at Coagulant Therapeutics, Inc. since August 2019, Daekyeong previously held the position of Venture Capitalist at Magellan Technology Investment, where responsibilities included sourcing and reviewing investment opportunities. Prior experience includes serving as Head of Business Development at Mirae Cell Bio, focusing on partnership opportunities for clinical candidates in the Asia-Pacific region, and working as a Research Scientist at Chabiotech, contributing to significant projects in stem cell research and securing two patents. Daekyeong earned a Ph.D. in Stem Cell Biology and a BSc in Biotechnology from University College London.